Company
Headquarters: New York, NY, United States
CEO: Dr. Steven Kafka Ph.D.
Company | Market Cap (USD) |
---|---|
Berkshire Hathaway | $887.16 B |
JPMorgan | $599.29 B |
Visa | $550.38 B |
Mastercard | $416.63 B |
Bank of America | $316.02 B |
DA32 Life Science Tech Acquisition Corp. focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. The company intends to identify business combination targets in the biotechnology and life science infrastructure sectors. DA32 Life Science Tech Acquisition Corp. was incorporated in 2021 and is based in New York, New York.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
DA32 Life Science Tech Acquisition Corp has the following listings and related stock indices.
Stock: NASDAQ: DALS wb_incandescent
Headquarters:
345 Park Avenue South
12th Floor
New York, NY 10010
United States
Phone: 212-551-1600